New hope for kids with rare eye muscle disease: drug trial launches
NCT ID NCT07298928
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 23 times
Summary
This study tests a new drug called Telitacicept in 30 children with ocular myasthenia gravis, a condition that causes eye muscle weakness. The goal is to see if the drug can better control symptoms and reduce the need for steroids, which have side effects. Participants will receive the drug and be monitored for safety and improvement in daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFECTIVENESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital Affiliated to Shandong University
Jinan, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shenzhen children's Hospital of China Medical University
Shenzhen, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.